Financial Contrast: Modular Medical (NASDAQ:MODD) vs. Carmell (NASDAQ:CTCX)

Modular Medical (NASDAQ:MODD) and Carmell (NASDAQ:CTCX) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, risk, valuation, earnings, institutional ownership, analyst recommendations and profitability.

Risk & Volatility

Modular Medical has a beta of 0.59, indicating that its share price is 41% less volatile than the S&P 500. Comparatively, Carmell has a beta of 0.32, indicating that its share price is 68% less volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of recent ratings and target prices for Modular Medical and Carmell, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Modular Medical	0	0	1	0	3.00
Carmell	0	0	0	0	0.00

Modular Medical currently has a consensus price target of $5.00, suggesting a potential upside of 194.12%. Given Modular Medical’s stronger consensus rating and higher probable upside, equities analysts clearly believe Modular Medical is more favorable than Carmell.

Earnings & Valuation

This table compares Modular Medical and Carmell”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Modular Medical	N/A	N/A	-$17.47 million	($0.63)	-2.70
Carmell	N/A	N/A	-$15.44 million	N/A	N/A

Institutional & Insider Ownership

27.5% of Modular Medical shares are held by institutional investors. Comparatively, 24.2% of Carmell shares are held by institutional investors. 32.3% of Modular Medical shares are held by company insiders. Comparatively, 29.0% of Carmell shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Profitability

This table compares Modular Medical and Carmell’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Modular Medical	N/A	-246.01%	-191.95%
Carmell	N/A	-217.50%	-50.22%

Summary

Modular Medical beats Carmell on 6 of the 9 factors compared between the two stocks.

About Modular Medical

Modular Medical, Inc. operates as a medical device company. It focuses on the design, development, and commercialization of insulin pumps. It offers MODD1, a two-part patch pump for type-1 and type-2 diabetes. The company is headquartered in San Diego, California.

About Carmell

Carmell Corporation operates as a bio-aesthetics company. The company utilizes Carmell Secretome to support skin and hair health. Its Carmell Secretome consists of growth factors and proteins extracted from allogeneic human platelets sourced from tissue banks. The company also developed a microemulsion formulation that enables delivery of lipophilic and hydrophilic ingredients without relying on the Foul Fourteen, 14 potentially harmful excipients that are commonly used by other companies to impart texture, stability, and other desirable physicochemical attributes to cosmetic products. In addition, the company is also developing a line of men's products and a line of topical haircare products. It has licensing agreement with Carnegie Mellon University to develop and commercialize biocompatible plasma-based plastics. The company was formerly known as Carmell Therapeutics Corporation and changed its name to Carmell Corporation in November 2023. Carmell Therapeutics Corporation was founded in 2008 and is headquartered in Pittsburgh, Pennsylvania.